Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
MEITUAN-W
03690
5
BEKE-W
02423
US Stock MarketDetailed Quotes
Avenue Therapeutics (ATXI)
- 0.8000
- +0.0499+6.65%
15min DelayClose Nov 11 14:08 ET
1.64MMarket Cap-0.07P/E (TTM)
0.8153High0.7800Low921Volume0.7800Open0.7502Prev Close737.46Turnover0.06%Turnover RatioLossP/E (Static)2.05MShares2.228952wk High0.63P/B1.20MFloat Cap0.165352wk Low--Dividend TTM1.50MShs Float13882.2750Historical High--Div Yield TTM4.71%Range %0.1653Historical Low0.8000Avg Price1Lot Size
Avenue Therapeutics (ATXI) Analyst Ratings, Stock Forecast and Price Target
ATXI Price Target for the Next 12 Months
No Data
Review Avenue Therapeutics earnings estimates
Detailed Ratings
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Download APP
Analyst Ratings Disclaimer
Market Insights
HK Tech and Internet Stocks HK Tech and Internet Stocks
Stocks of companies primarily involved in technology and internet sectors in the HK stock market. Stocks of companies primarily involved in technology and internet sectors in the HK stock market.
View More
Nancy Pelosi Portfolio Nancy Pelosi Portfolio
Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns. Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns.
Hot Topics
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome
牛牛課堂
Oct 13 18:05
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?